Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

379 ARTÍCULOS , VIENDO DEL 166 AL 180

Whatever happened to new treatments for Alzheimer's disease?

Devanand DP.

J Clin Psychiatry. 2014 Jul;75(7):775-6. doi: 10.4088/JCP.14ac09246.

Toll-like receptors in Alzheimer's disease: a therapeutic perspective

Gambuzza ME, Sofo V, Salmeri FM, Soraci L, Marino S, Bramanti P.

CNS Neurol Disord Drug Targets. 2014;13(9):1542-58. doi: 10.2174/1871527313666140806124850.

Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease

McClean PL, Hölscher C.

Neuropharmacology. 2014 Nov;86:241-58. doi: 10.1016/j.neuropharm.2014.07.015. Epub 2014 Aug 8.

Pharmacogenomics of Alzheimer's disease: novel therapeutic strategies for drug development

Cacabelos R, Cacabelos P, Torrellas C, Tellado I, Carril JC.

Methods Mol Biol. 2014;1175:323-556. doi: 10.1007/978-1-4939-0956-8_13.

Towards understanding the roles of heparan sulfate proteoglycans in Alzheimer's disease

Zhang GL, Zhang X, Wang XM, Li JP.

Biomed Res Int. 2014;2014:516028. doi: 10.1155/2014/516028. Epub 2014 Jul 23.

Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial

Farokhnia M, Shafiee Sabet M, Iranpour N, Gougol A, Yekehtaz H, Alimardani R, Farsad F, Kamalipour M, Akhondzadeh S.

Hum Psychopharmacol. 2014 Jul;29(4):351-9. doi: 10.1002/hup.2412.

Playing games with the brain: the possible link between anesthesia and Alzheimer's disease revisited

Lobo FA, P Saraiva A.

Rev Esp Anestesiol Reanim. 2014 Oct;61(8):417-21. doi: 10.1016/j.redar.2014.07.008.

SAR studies on carboxylic acid series M(1) selective positive allosteric modulators (PAMs)

Kuduk SD, Beshore DC.

Curr Top Med Chem. 2014;14(15):1738-54. doi: 10.2174/1568026614666140826120224.

Transdermal rivastigmine in the treatment of Alzheimer's disease: current and future directions

Amanatkar HR, Grossberg GT.

Expert Rev Neurother. 2014 Oct;14(10):1119-25. doi: 10.1586/14737175.2014.955852. Epub 2014 Sep 9.

Mechanisms of action of phytochemicals from medicinal herbs in the treatment of Alzheimer's disease

Kim MH, Kim SH, Yang WM.

Planta Med. 2014 Oct;80(15):1249-58. doi: 10.1055/s-0034-1383038. Epub 2014 Sep 11.

Pregnane X Receptor and P-glycoprotein: a connexion for Alzheimer's disease management

Jain S, Rathod V, Prajapati R, Nandekar PP, Sangamwar AT.

Mol Divers. 2014 Nov;18(4):895-909. doi: 10.1007/s11030-014-9550-6. Epub 2014 Sep 12.

Mitochondrial dysfunction: different routes to Alzheimer's disease therapy

Picone P, Nuzzo D, Caruana L, Scafidi V, Di Carlo M.

Oxid Med Cell Longev. 2014;2014:780179. doi: 10.1155/2014/780179. Epub 2014 Aug 20.

Assay suitability for natural product screening: searching for leads to fight Alzheimer's disease

Vasänge M.

Planta Med. 2014 Sep;80(14):1200-9. doi: 10.1055/s-0034-1383063. Epub 2014 Sep 15.

Link between chronic bacterial inflammation and Alzheimer disease

Bibi F, Yasir M, Sohrab SS, Azhar EI, Al-Qahtani MH, Abuzenadah AM, Kamal MA, Naseer MI.

CNS Neurol Disord Drug Targets. 2014;13(7):1140-7. doi: 10.2174/1871527313666140917115741.

Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease

Morris GP, Clark IA, Vissel B.

Acta Neuropathol Commun. 2014 Sep 18;2:135. doi: 10.1186/s40478-014-0135-5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias